Dr. Sarah Fortune, a Harvard immunologist, faces a sudden halt to her tuberculosis research due to the Trump administration's freeze on $2.2 billion in funding. This marks a significant escalation in the administration's broader campaign against elite universities, affecting various critical research projects, including A.L.S. diagnostics and studies of space travel. Despite Harvard's efforts to collaborate with the White House, the expanded demands raised new concerns, with the administration framing the cuts as part of an effort to address antisemitism while seemingly unrelated to the research itself.
Dr. Sarah Fortune, an immunologist at Harvard, is caught in a conflict over federally funded tuberculosis research due to the Trump administration's funding freeze.
The Trump administration's campaign against elite universities could cut $2.2 billion in research funding, severely impacting projects at Harvard and other institutions.
The administration's language suggests that cuts are framed as a response to antisemitism, despite expanding demands that are unrelated to that issue.
Dr. Fortune's work on tuberculosis research, crucial for global health, now faces jeopardy as the administration enforces substantial funding cuts across leading universities.
Collection
[
|
...
]